Insider Ledger
Entera Bio Ltd. (ENTX) insider buying and SEC filings
Entera Bio Ltd. · CIK 1638097
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- L3
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$133K
Insiders who bought
5
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 9, 2026 | Purchase (code P) | Geno J Germano (Director) bought 20,000 shares at $1.30 ($26K), reported as a purchase (code P). Holdings up 100% to 40,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 5, 2026 | Purchase (code P) | Sean Ellis (Director) bought 10,000 shares at about $1.23 ($12K), reported as a purchase (code P). Holdings up 6% to 188,098 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Feb 12, 2026 | Purchase (code P) | Steven D Rubin (Director) bought 5,000 shares at $1.49 ($7K), reported as a purchase (code P). Holdings up 50% to 15,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 10, 2026 | Purchase (code P) | Haya Taitel (Director) bought 7,500 shares at about $1.48 ($11K), reported as a purchase (code P). Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 10, 2026 | Purchase (code P) | Geno J Germano (Director) bought 20,000 shares at $1.49 ($30K), reported as a purchase (code P). Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 9, 2026 | Purchase (code P) | Steven D Rubin (Director) bought 10,000 shares at $1.20 ($12K), reported as a purchase (code P). New position of 10,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 9, 2026 | Purchase (code P) | Sean Ellis (Director) bought 18,000 shares at about $1.24 ($22K), reported as a purchase (code P). Holdings up 11% to 178,098 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Dec 29, 2025 | Purchase (code P) | Miranda Jayne Toledano (CEO and Director) bought 11,000 shares at about $1.81 ($20K), reported as a purchase (code P). Holdings up 3% to 426,575 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$114K in purchases since Feb 9, 2026 · Purchases traded Feb 9, 2026 to Mar 9, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Sean Ellis (Director) | $22K | Feb 9, 2026 | SEC filing |
| Steven D Rubin (Director) | $12K | Feb 9, 2026 | SEC filing |
| Geno J Germano (Director) | $30K | Feb 10, 2026 | SEC filing |
| Haya Taitel (Director) | $11K | Feb 10, 2026 | SEC filing |
| Sean Ellis (Director) | $12K | Mar 5, 2026 | SEC filing |
| Geno J Germano (Director) | $26K | Mar 9, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ENTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.